INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (3)
2024
-
Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study
Journal of Clinical Medicine, Vol. 13, Núm. 6
2018
-
A computational framework for complex disease stratification from multiple large-scale datasets
BMC Systems Biology, Vol. 12, Núm. 1
2017
-
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
Journal of Allergy and Clinical Immunology, Vol. 139, Núm. 6, pp. 1797-1807